Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Adaptation of suspension Vero cells to commercially available cell culture media and enhanced production of vaccine‐strain mumps virus. Local targets link to admitted publications; unresolved targets remain external evidence.
Production of a foot‐and‐mouth disease vaccine antigen using suspension‐adapted BHK‐21 cells in a bioreactor
10.3390/vaccines9050505 · 2021 · External reference
Scale‐up Technologies for the Manufacture of adherent cells
10.3389/fnut.2020.575146 · 2020 · External reference
Influence of hydrodynamic shear stress on microcarrier‐attached cell growth: cell line dependency and surfactant protection
10.1007/s004490050663 · 1999 · External reference
The protective effect of serum against hydrodynamic damage of hybridoma cells in agitated and surface‐aerated bioreactors
10.1016/0168-1656(90)90051-c · 1990 · External reference
Cell confluency analysis on microcarriers by micro‐flow imaging
10.1007/s10616-016-9967-0 · 2016 · External reference
Investigation into the use of gamma irradiated Cytodex‐1 microcarriers to produce a human cytomegalovirus (HCMV) vaccine candidate in epithelial cells
10.1016/j.jbiotec.2023.02.005 · 2023 · External reference
Attachment and detachment strategies in microcarrier‐based cell culture technology: a comprehensive review
10.1016/j.msec.2019.109782 · 2019 · External reference
Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine,Rotarix™
10.4161/hv.25973 · 2013 · External reference
A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions
10.1016/j.vaccine.2007.01.086 · 2007 · External reference
Development and scale‐up of rVSV‐SARS‐CoV‐2 vaccine process using single use bioreactor
10.1016/j.btre.2023.e00782 · 2023 · External reference
Recombinant protein therapeutics from CHO cells‐20 years and counting
2007 · External reference
HEK293 cell line as a platform to produce recombinant proteins and viral vectors
2021 · External reference
The baculovirus expression vector system: a commercial manufacturing platform for viral vaccines and gene therapy vectors
10.1002/biot.201400438 · 2015 · External reference
Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing
10.1002/bit.22723 · 2010 · External reference
Anoikis‐resistant MDCK cells carrying susceptibilities to TNF‐α and verotoxin that are suitable for influenza virus cultivation
10.1007/s10616-006-9032-5 · 2006 · External reference
Serum‐free production of recombinant proteins and adenoviral vectors by 293SF‐3F6 cells
10.1002/(sici)1097-0290(19980905)59:5<567::aid-bit6>3.0.co;2-8 · 1998 · External reference
10.1038/1951163a0
10.1038/1951163a0 · External reference
The use of HeLa cells in suspension for the quantitative study of virus propagation
10.1016/0042-6822(56)90009-5 · 1956 · External reference
Establishing suspension cell cultures for improved manufacturing of oncolytic adenovirus
10.1002/biot.201900411 · 2020 · External reference
New helper cells and matched early region 1‐deleted adenovirus vectors prevent generation of replication‐competent adenoviruses
10.1089/hum.1998.9.13-1909 · 1998 · External reference
CAP, a new human suspension cell line for influenza virus production
10.1007/s00253-012-4238-2 · 2013 · External reference
Life cycle analysis of mammalian cells: II. Cells from the Chinese hamster ovary grown in suspension culture
10.1016/s0006-3495(64)86794-1 · 1964 · External reference
10.1006/biol.1998.0153
10.1006/biol.1998.0153 · External reference
Suspension‐Vero cell cultures as a platform for viral vaccine production
10.1016/j.vaccine.2009.06.020 · 2009 · External reference
Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media
10.1016/j.vaccine.2019.05.092 · 2019 · External reference
Development of suspension adapted Vero cell culture process technology for production of viral vaccines
10.1016/j.vaccine.2019.07.003 · 2019 · External reference
Bioreactor production of rVSV‐based vectors in Vero cell suspension cultures
10.1002/bit.27785 · 2021 · External reference
Vero cells gain renal tubule markers in low‐calcium and magnesium chemically defined media
10.1038/s41598-022-10221-z · 2022 · External reference
The growth factor inhibitor suramin reduces apoptosis and cell aggregation in protein‐free CHO cell batch cultures
10.1021/bp0000353 · 2000 · External reference
Influenza virus neuraminidase contributes to the dextran sulfate‐dependent suppressive replication of some influenza a virus strains
10.1016/j.antiviral.2012.09.012 · 2012 · External reference
Antiviral activity of low‐MW dextran sulphate (derived from dextran MW 1000) compared to dextran sulphate samples of higher MW
10.1177/095632029100200307 · 1991 · External reference
Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins
10.1128/aac.35.12.2515 · 1991 · External reference
Vaccine supply chains: priority areas of action emerging from the COVID‐19 pandemic
10.18609/vac.2023.011 · 2023 · External reference
Comparative analysis of the complete nucleotide sequences of measles, mumps, and rubella strain genomes contained in Priorix‐tetra™ and ProQuad™ live attenuated combined vaccines
10.1016/j.vaccine.2009.01.112 · 2009 · External reference
Live attenuated mumps virus vaccine. 1. Vaccine development
10.3181/00379727-123-31599 · 1966 · External reference
Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche
10.1007/bf01863914 · 1931 · External reference
Exploring progress with supply chain risk management during the first year of the COVID‐19 pandemic
10.3390/logistics5040070 · 2021 · External reference
Tumorigenicity of Vero cells
10.1016/s0092-1157(84)80063-3 · 1984 · External reference
Characterization of a suspension Vero cell line for viral vaccine production
10.1038/s41541-025-01157-2 · 2025 · External reference
The molecular weight and concentration of dextran sulfate affect cell growth and antibody production in CHO cell cultures
10.1002/btpr.2287 · 2016 · External reference
A comparative study of the effect of dextran sulfate on the fusion and the in vitro replication of influenza A and B, Semliki Forest, vesicular stomatitis, rabies, Sendai, and mumps virus
10.1007/bf01309663 · 1993 · External reference
Amino acid change 335 E to K affects the sialic‐acid‐binding and neuraminidase activities of Urabe AM9 mumps virus hemagglutinin–neuraminidase glycoprotein
10.1016/j.micinf.2006.11.011 · 2007 · External reference
Unresolved reference
1996 · External reference
Impact of dextran sulfate in culture media on titration of vesicular stomatitis virus
10.1016/j.jviromet.2019.113758 · 2020 · External reference
